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Supplementary Figure 1. Additional images and graphs related to Figures 1-3.  
a-d) 3D projections (left) and ductal reconstruction (middle and right) of islet clones showing: 
(a) tripotent islet-ductal-acinar clone; different size ratios of islet to ductal component with (b) 
showing minority ductal labelling, (c) minority islet labelling, and (d) similar ductal and islet 
labelling in bipotent clones. e-g) 3D projections (left) and ductal reconstruction (right) of islet 
clones displaying different fractions of co-localisation within the islet with (e) whole islet 
labelling in a bipotent clone, (f) partial islet labelling in a unipotent clone, and (g) sparse islet 
labelling in a unipotent clone. Purple shows ducts reconstructed based exclusively on intensity 
of Chromogranin A and DBA, as described in Ref. 6. Chromogranin A is grey and DBA is white. 
(a-g) are representative of >20 images from 3 experiments for (a) and >15 images each for 
(b-g). h) Fraction of islets with a given number of colours for E9.5-P14 (n=874 islets from N=5 
mice) and E12.5-P14 tracings (n=214 islets from N=3 mice). Error bars show mean±SD. i) 
Relationship between ductal and islet component of multipotent clones. j) Cumulative clone 
size distribution for clone volumes for E9.5-P14 tracing (n=93 clones from N=5 mice). Dashed 
line shows an exponential fit. Error bars show mean±SD. k) Relationship between islet clone 
volume and islet volume for E9.5-P14 tracings. l) Poly-islet structures observed at E18.5 with 
clones traced between E12.5 and E18.5 (left inset), representative of 15 images from 4 
experiments. The right inset shows a zoom on an islet doublet with labelled cells present in 
only one of the islet domains. White arrows indicate constriction point in the doublet. m) 
Cumulative clone size distribution of islet clone fragments traced from E9.5 (blue) or E12.5 
(red) to P14. Points represent data and lines a log-normal fit, as expected theoretically based 
on random merger and fragmentation of clusters, showing excellent fits at both timepoints. n) 
Schematic representing the stochastic proliferation of equipotent progenitors (left) and the 
deterministic proliferative output of stem cell-like population (right), with the corresponding 




Supplementary Figure 2. Additional images and graphs related to Figure 4.  
a-c) Combinations of channels for sections of 3D images in Fig. 4b-d. Representative clones 
for E12.5-P14 tracings with 100µm sections co-stained with insulin and glucagon: d) α-cell 
unipotent, e) β-cell unipotent, and f) α/β-cell bipotent clone. (d-f) are representative of, 
respectively, >20, 45, >60 images from 4 experiments each. Insulin is grey, glucagon is pink, 
DAPI is blue. Arrows (arrowheads) indicate insulin+ and (glucagon+) cells. Representative 
image of chromogranin A and DBA immunostaining of g) E15.5 and h) E18.5 tissue, based 
on> 10 images from 4 and 3 experiments, respectively, with latter showing areas with small 
chromogranin A+ clusters (top-right inset) and more islet-shaped clusters (bottom-right inset). 
Images of E12.5-E18.5 traced clones representative of 3 experiments (based on >10 images 
each) showing i) a more separated clone and j,k) clones clustered at interface of DBA+ and 
Chromogranin A+ areas with a zoom on cells displaying double-positive characteristics. 
Representative images of pancreatic tissue at E14.5 immunostained for l) insulin and DBA 
(N=3 mice, representative of >10  images) and m) glucagon and DBA (N=3 mice, 
representative of >10 images), shown as large areas (right) and zooms (left), with occasional 
small areas with double-positive insulin+ DBA+ and glucagon+ DBA+, respectively (arrow). 
n,o) Outcome of lineage tracing analysis for E12.5-E14.5, E12.5-E15.5 and E12.5-E18.5 
tracings (N=3,5,3 mice, respectively), combined with immunostaining of insulin and DBA, or 
glucagon and DBA, showing progressive increase in fraction of clones contributing to 
hormone+ lineages between E15.5 and E18.5. Fraction of clones contributing to DBA+ and 
hormone+ cells (DBA+hormone+), to hormone+ cells only (DBA-hormone+), to ductal cells 
only (DBA+hormone-), or to neither lineage (DBA-hormone-). Representative images (based 
on at least 5 images each) for clones traced from E12.5 to p) E14.5, q) E15.5, and r) E18.5 
for insulin/DBA and glucagon/DBA analyses. Asterisk indicates non-DBA non-hormone cell, 
arrowhead indicates DBA+ cell, arrow indicates hormone+ cell. Hormone+ clones, hormone+ 
cell-containing clones, primitive ductal epithelium (PDE) clones, PDE cell-containing clones, 
hormone+ and PDE+ cell-containing clones are shown. (N=3 mice, n=105 clones for E14.5 
insulin/DBA; N=3 mice, n=104 clones for E14.5 glcg/DBA; N=5 mice, n=140 clones for E15.5 
insulin/DBA; N=5 mice, n=137 clones for E15.5 glcg/DBA; N=3 mice, n=58 clones for E18.5 
insulin/DBA; N=3 mice, n=65 clones for E14.5 for glcg/DBA). 

Supplementary Figure 3. Additional graphs and images related to Figure 4.  
a) Fraction of β-cells (normalized to α+β-cells) (n=36 islets from N=4 mice) in all clones traced 
from E12.5-P14 as well as bipotent α,β-cell clones and combination of unipotent α- or β-cell 
clones (n=138 clones from N=4 mice; one mouse with few β-cells overall consisted of only 7 
clones). Error bars show average±SD. b) Size of clones traced from E12.5-P14 showing no 
statistically significant differences between unipotent α- and β-cell clones (n=30 and n=43 
clones from N=4 mice, respectively). Error bars show average±SD. c) Predicted (dots) and 
experimental (dashed) fraction of bipotent clones as a function n/N (see main text). d) Average 
α-cell size shown as function of β-cell size in clones traced from E12.5-P14. Data shown as 
points (n=138 clones from N=4 mice) and fit as line with shading representing 95% confidence 
interval. Based on scarcity of clones, the data point for largest β-cell count combines several 
entries (Methods). Error bars show average±SD. e) Predicted joint distribution of α- and β-cell 
number in islet clones from E12.5-P14 tracings (reproduced from Fig. 4i for comparison with 
g,h,l). f) Experimental (dots) vs. theoretical (line) variance in α-cell size as function of β-cell 
size in E12.5 clones, supporting model of stochastic α/β-cell fate allocation. Shaded areas 
represent 95% confidence intervals.  Sensitivity analysis: Predicted joint distribution of α- vs. 
β-cell numbers in E12.5 clones for g) early or h) late commitment. i) Corresponding mean α-
cell clone size as function of β-cell clone size, compared to best fit (Fig. 4i). j) Alternative model 
with continuous specification of α- and β-cells predicts incorrect correlation between α- and β-
cell clone size (n=138 clones from N=4 mice, Methods). Error bars show average±SD. k) 
Cumulative total clone size distribution under null hypothesis (best fit from Fig. 4 where α- and 
β-cells have same proliferation rate, purple), or under alternative model where β-cells 
proliferate much faster than α-cells (division rate of β-cells doubled and α-cells halved, 
n/N=0.333). Shows that exponential distributions only expected in absence of substantial 
population heterogeneity. l) Predicted joint distribution of α- vs. β-cell numbers in E12.5 clones 
when, on average, one apoptosis event takes place per clone per time course, balanced by 
increase of average division number to N=3.5, and all other parameters kept constant, 
showing that results are largely insensitive to small rates of cell loss. m) Cumulative clone size 
distribution (total black, α-cells purple, β-cells blue) in data (n=138 clones from N=4 mice) vs. 
alternative model (lines) in which 50% of induced clones are unipotent and the rest are 
bipotent (Methods), showing non-exponential dependencies. Error bars show average±SD. n-
p) Representative images from 3 experiments each based on >10 recorded images each of 
tissue immunostained for Caspase 3 at E14.5, E15.5 and E18.5 showing only a few Caspase 
3+ cells labelled by asterisk on left and zoom in insets on right. Source data provided as 
Source Data file. 
 

Supplementary Figure 4. Additional images related to Figures 4 and 5.  
Representative clones for the a-c) E15.5-P14 and d-f) E18.5-P14 R26-CreERT2/R26R-
Confetti traced clones within thick 100µm sections co-stained with insulin and glucagon 
presented as 3D projection and zoomed individual Z-stacks: a,d) unipotent insulin+ clones, 
b,e) unipotent glucagon+ clones, and c,e) bipotent clones. Grey is insulin, pink is glucagon, 
DAPI is blue. Images representative of at least 10 recorded images from 3 experiments for 
each tracing. Negative control for Ngn3-CreER lineage tracing. g) Majority of tissue showed 
no GFP expression, with h) rarely labelled islets (2 labelled islets observed in 3 pancreata). 
Insulin is red, glucagon is white, DAPI is blue. Representative images based on 30 recorded 
images from N=3 mice. Labelling efficiency in induced mice is shown in Fig. 5b. 
 

Supplementary Figure 5. Additional images related to Figure 5.  
Predicted joint distribution of α- and β-cell numbers in clones traced from a) E15.5-P14 and b) 
E18.5-P14, displaying markedly reduced degree of bipotency compared to E12.5 tracing (Fig. 
4), and good agreement with data (Fig. 4j,k). n=40 clones from N=3 mice. Error bars show 
average±SD. Average α-cell compartment size as a function of β-cell size, showing both data 
(dots) and theory (lines) for c) E15.5 and d) E18.5 tracings. Shaded areas represent 95% 
confidence intervals. n=65 clones from N=3 mice. Error bars show average±SD. e) Potency 
of E15.5 (top, orange) and E18.5 (bottom, green) clones compared to model prediction (same 
parameters as Fig. 4j,k). n=40 clones from N=3 mice for E15.5-P14 tracings, n=65 clones from 
N=3 mice for E18.5-P14 tracings. Error bars show average±SD. f) Fraction of β-cells in P14 
islets (n=36 islets from N=4 mice) and islet clones traced from E15.5-P14 and E18.5-P14. 
n=40 clones from N=3 mice for E15.5-P14 tracings, n=65 clones from N=3 mice for E18.5-
P14 tracings. Error bars show average±SD. Experimental (dots) vs. theoretical (line) variance 
in α-cell compartment size as a function of β-cell size in g) E15.5 and h) E18.5 clones, showing 
that model of stochastic α/β-cell fate allocation provides good fit to data. n=40 clones from 
N=3 mice for E15.5-P14 tracings, n=65 clones from N=3 mice for E18.5-P14 tracings. i) Clone 
sizes for unipotent α- and β-cell clones for E12.5-P14, E15.5-P14, and E18.4-P14 tracings, 
showing significant differences (P>0.2, two-tailed Mann-Whitney tests). n=40 clones from N=3 
mice for E15.5-P14 tracings, n=65 clones from N=3 mice for E18.5-P14 tracings. Error bars 
show average±SD. j) Representative image (based on >30 recorded images) of E12.5-P28 
traced clone (N=3 mice), showing expansion of insulin+ cell compartment. Insulin is grey, 
glucagon is pink. k) Size and potency of P28 clones induced at E12.5. Left panel: Mean size 
for α- and β-cell compartment in bipotent clones at P14 and P28 showing that, while α-cells 
do not expand in number between P14 and P28 (P=0.88, two-tailed Mann-Whitney test), β-
cells expand by a factor of ~2 (P=0.04, two-tailed Mann-Whitney test), leading to significantly 
different sizes (P=0.001 at P14, P=0.002 at P28, two-tailed Mann-Whitney tests). Error bars 
show average±SD. l) Clone potency at P28, displaying similar degree of bipotency as P14 
clones (Fig. 4f). Error bars show average±SD. m) Experimental (dots) vs. theoretical (lines) 
cumulative size distribution of clones induced at E12.5 and traced until P28 (total purple, α-
cell cyan, β-cell green). Data is well-fit by an exponential, as expected for stochastic 
duplications and fate choices. n=33 clones from N=3 mice. Error bars show average±SD. n,o) 
Experimental (left) vs. theoretical (right) joint distribution of α vs. β-cell numbers in clones 
traced from E12.5-P28. n=33 clones from N=3 mice. Source data provided as Source Data 
file. 
